Daniel Gordon Kirby - 24 Feb 2026 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Chief Commercial Officer
Signature
/s/ Daniel Gordon Kirby
Issuer symbol
IOVA
Transactions as of
24 Feb 2026
Net transactions value
-$129,144
Form type
4
Filing time
26 Feb 2026, 17:00:18 UTC
Previous filing
12 Feb 2026
Next filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kirby Daniel Gordon Chief Commercial Officer C/O IOVANCE BIOTHERAPEUTICS, INC., 825 INDUSTRIAL ROAD, SUITE 100, SAN CARLOS /s/ Daniel Gordon Kirby 26 Feb 2026 0002055001

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOVA Common Stock Options Exercise $0 +120,000 +224% $0.000000 173,546 24 Feb 2026 Direct F1
transaction IOVA Common Stock Tax liability $129,144 -34,165 -20% $3.78 139,381 24 Feb 2026 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOVA Restricted Stock Units Options Exercise $0 -150,000 -100% $0.000000 0 24 Feb 2026 Common Stock 150,000 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of the Issuer's common stock underlying performance-based restricted stock units ("PSUs") that have been earned based on the level of achievement of certain financial milestones. The earned PSUs vested on February 24, 2026.
F2 Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the PSUs. This is not an open market sale of securities.
F3 Represents the common stock remaining after deducting the common stock withheld for taxes.
F4 Each PSU represents a contingent right to receive one share of the Issuer's common stock.
F5 On February 10, 2025, the Reporting Person was granted an award of up to 150,000 PSUs, which vests in the form of shares of the Issuer's common stock upon the achievement of certain financial milestones. On February 24, 2026, certain financial milestones were met, resulting in the vesting of the PSUs as to 120,000 of the underlying shares and the cancellation of the PSUs as to 30,000 of the underlying shares.